"Thrombin Time" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clotting time of PLASMA mixed with a THROMBIN solution. It is a measure of the conversion of FIBRINOGEN to FIBRIN, which is prolonged by AFIBRINOGENEMIA, abnormal fibrinogen, or the presence of inhibitory substances, e.g., fibrin-fibrinogen degradation products, or HEPARIN. BATROXOBIN, a thrombin-like enzyme unaffected by the presence of heparin, may be used in place of thrombin.
| Descriptor ID |
D013918
|
| MeSH Number(s) |
E01.370.225.625.115.870 E05.200.625.115.870 G09.188.840
|
| Concept/Terms |
Thrombin Time- Thrombin Time
- Thrombin Times
- Time, Thrombin
- Times, Thrombin
- Reptilase Time
- Reptilase Times
- Time, Reptilase
- Times, Reptilase
|
Below are MeSH descriptors whose meaning is more general than "Thrombin Time".
Below are MeSH descriptors whose meaning is more specific than "Thrombin Time".
This graph shows the total number of publications written about "Thrombin Time" by people in this website by year, and whether "Thrombin Time" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 0 | 1 | 1 |
| 2017 | 2 | 4 | 6 |
| 2018 | 0 | 3 | 3 |
| 2019 | 0 | 2 | 2 |
| 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Thrombin Time" by people in Profiles.
-
Coronavirus-induced coagulopathy during the course of disease. PLoS One. 2020; 15(12):e0243409.
-
D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis. Biomed Res Int. 2020; 2020:6159720.
-
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020 07; 92(7):791-796.
-
A Retrospective Analysis of the Coagulation Dysfunction in COVID-19 Patients. Clin Appl Thromb Hemost. 2020 Jan-Dec; 26:1076029620964868.
-
Heparin and citrate additive carryover during blood collection. Clin Chem Lab Med. 2019 Nov 26; 57(12):1888-1896.
-
Lessons learnt from local real-life experience with idarucizumab for the reversal of dabigatran. Intern Med J. 2019 Jan; 49(1):59-65.
-
Analytical performance of the new D-dimer and antithrombin assay on Roche cobas t 711 analyzer. Int J Lab Hematol. 2019 06; 41(3):e54-e56.
-
How and when to measure anticoagulant effects of direct oral anticoagulants? Practical issues. Pol Arch Intern Med. 2018 06 29; 128(6):379-385.
-
Thrombin generation and platelet activation in cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy - A prospective cohort study. PLoS One. 2018; 13(6):e0193657.
-
Emergency Coagulation Assessment During Treatment With Direct Oral Anticoagulants: Limitations and Solutions. Stroke. 2017 09; 48(9):2457-2463.